Screen the entire global market — including names the crowd has left for dead — by quality, growth, returns and valuation.
Every subsector ranked on valuation, income, returns and leverage, computed from our own company financials with a book-value NAV proxy. Click a subsector for its full report.
The full investment thesis appears here once research has run. Financials, prices and filings below are live.
| $ millions | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
Annual financial statements as reported, going back as far as the data allows.
| $m | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
| $m | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
| $m | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
Sector-specific KPIs extracted from the company's published annual and interim reports, each traceable to its source document.
A 10-year unlevered DCF — pick a case above; every assumption below is a live control and the fair value, projection and sensitivity recompute as you move them.
| $m | FY26E | FY27E | FY28E | FY29E | FY30E | FY31E | FY32E | FY33E | FY34E | FY35E |
|---|
The ten years of present-valued free cash flow are summed, a Gordon-growth terminal value is added for everything beyond year ten, net debt is subtracted, and the result is divided by the share count. Every number here is live — move any assumption on the left and the whole waterfall, the bridge and the sensitivity grid recompute.
Every number here is live — move any assumption on the left and the whole waterfall, the bridge and the sensitivity grid recompute from this company’s own financials.
The qualitative work behind the thesis — what the business is, how defensible it is, and where it goes next.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
This section appears once research has run for this company.
Source documents straight from the database — click to read the raw filing or release. Our read on what matters lives in Recent developments.
Upcoming and recent investor events — results, AGM, dividend and ex-dividend dates — from the company's own investor calendar.
Every place this issuer trades — the home listing, foreign cross-listings and depositary receipts (ADR/CDR/BDR), plus any separate share classes. The screener shows one canonical line per company; the rest live here.
| Listing | Exchange | Ticker | Currency | Price | Type |
|---|
Interactive price chart with the common technical-analysis overlays and indicators — moving averages, Bollinger Bands, volume, RSI and MACD — plus an at-a-glance momentum summary. Use the chart's own toolbar to add or remove studies, change timeframe, or search a different listing.
A note on method: PrimerIQ's research is built bottom-up from the filings — what a business earns and what it's worth. The charts below read price history, not the business; we include them because many investors want them, not because they drive our valuation. Treat them as one lens among several.
Relative strength percentile: 99 vs market, 95 vs industry. Momentum rank is a 0–100 percentile across 35,415 companies — one lens, not a valuation signal.
Charts and technical data by TradingView. Not investment advice.
The full webcast audio, transcribed, with structural signals the transcript text alone loses — how scripted vs spontaneous the language is, where management hesitated longest, and which answers were most hedged. These are flags for attention, not verdicts; read the transcript and judge for yourself.
This company's place in the value chain — the suppliers, customers, competitors and partners it names in its own filings, the industries it operates in, and where it's based. Double-click any company to expand its network, or an industry to pull in its peer companies; click a link to read the exact passage that evidences it. Run a what-if to see who plausibly benefits or is exposed if this company thrives, struggles, or is hit by a shock. Relationships are what companies disclose, not statistical peers; second-order effects are model-derived hypotheses, cited to the filings, not predictions.
Relationships are extracted from company filings. Untyped links are co-mentions (may include peer comparisons); typed links and what-if scores are model-derived and cited — treat as hypotheses, not advice.
Select a filing on the left to read it here.
Select a filing to view its raw text.